COLLPLANT BIOTECHNOLOGIES REPORTS 2024 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Provided By PR Newswire
Last update: Aug 20, 2024
- Recently initiated a pre-clinical trial with CollPlant's rhCollagen-based regenerative breast implants, printed with Stratasys' Origin® 3D printer that are 200cc in volume
Read more at prnewswire.comNASDAQ:CLGN (2/21/2025, 8:09:58 PM)
3.47
-0.01 (-0.22%)
11.19
-0.33 (-2.86%)
Find more stocks in the Stock Screener
